News

Wan Xu, PhD, recently joined Duke Center for Applied Genomics & Precision Medicine (CAGPM) as a Biostatistician III. To get to know Dr. Xu a little more, we asked her the following questions:

From the Director

The Duke Center for Applied Genomics & Precision Medicine welcomes our two new Post-Doctoral Training in Genomic Medicine Research trainees, Nathan Hawkey, MD, and Katherine Collins, PhD. CAGPM postdoc's are supported through T32 grant funding.

From the Director

As we honor Veterans Day today, the Duke Center for Applied Genomics & Precision Medicine (CAGPM) thanks all the current service members, the many veterans who have courageously served our country and their families who have supported these individuals. Our appreciation goes beyond Veterans Day, though, as researchers at the Durham VA Health Care System, Duke, and CAGPM, including Douglas E. Williamson, PhD, are advocates for the well-being of these individuals through their studies of genomic biomarkers that hold promise for improving support for the many service members and veterans who rely on mental health care post-deployment and beyond.

Jennifer Doudna, PhD, professor of chemistry, biochemistry, and molecular biology at the University of California, Berkeley, recently presented virtually as the Duke MEDx 2021 Distinguished lecturer.

The November 09, 2021, session of Duke Medicine LEADS featured Sebastian Franco, MD, Brittany Chapman, MD, Nathan Hirshman, MD, Dilraj Grewal, MD, Carlos De Castro, MD, presenting "P

Catch up with the Duke Internal Medicine Residency Program by reading the weekly newsletter for November 8, 2021.

Geoffrey S. Ginsburg, MD, PhD, a professor of medicine in cardiology, a professor in pathology, biostatistics and bioinformatics, a professor of biomedical engineering, and a professor in Duke’s School of Nursing, will leave Duke to assume the role of Chief Medical and Scientific Officer for the National Institutes of Health (NIH) All of Us Research Program, effective January 2022. Dual announcements were made on Nov. 3 by the NIH and Duke School of Medicine.

New research continues to be explored through the growing progress in genome sequences but concurrently these advances have produced a diversity of new issues to be addressed.